{"podcast":{"title":"Vancouver News Today | 2 Min News | The Daily News Now!","slug":"vancouver-news-today-2-min-news-the-daily-news-now-7592122","podcast_index_feed_id":7592122,"rss_url":"https://feeds.fastcast.ai/the-santa-ana-daily-news-now.xml","website_url":"https://thednn.ai/","image_url":"https://image.fastcast.ai/podcasts/the-santa-ana-daily-news-now.jpg","author":"The Daily News Now!","episode_count":2413,"summary":"Hosted by Corey with the Story, Vancouver News Today delivers daily coverage of everything happening in Vancouver with fast, focused updates on local news, government, business, public safety, weather, and the stories shaping the city. From downtown developments to regional updates, the show keeps you informed on what matters most across Vancouver. Each short episode highlights what matters most—including key updates, local trends, and stories shaping the city—produced by AI for speed, consistency, and clarity. Part of The Daily News Now network, Vancouver News Today is built for listeners who want reliable local news coverage in a quick, easy-to-digest format. Advertise on DNN: advertise@thednn.ai","last_synced_at":"2026-07-31T14:19:23.938967+00:00","page_url":"https://stenobird.com/podcast/vancouver-news-today-2-min-news-the-daily-news-now-7592122"},"episode":{"title":"Pfizer’s Bold Move in Weight Loss Drugs","slug":"pfizer-s-bold-move-in-weight-loss-drugs","published_at":"2026-06-06T14:50:58+00:00","page_url":"https://stenobird.com/podcast/vancouver-news-today-2-min-news-the-daily-news-now-7592122/pfizer-s-bold-move-in-weight-loss-drugs","show_page_url":"https://stenobird.com/podcast/vancouver-news-today-2-min-news-the-daily-news-now-7592122","url":"https://api.fastcast.ai/audio/b9de3813-f102-4e65-8f9f-521ef06b97c6.mp3","audio_url":"https://api.fastcast.ai/audio/b9de3813-f102-4e65-8f9f-521ef06b97c6.mp3","summary":"Pfizer is betting big on weight-loss drugs, unveiling promising data for berobenatide—a once-monthly shot that slashed 16% of body weight in trials. Acquired for $10 billion, the drug could disrupt the market dominated by Eli Lilly and Novo Nordisk, offering a major advantage over weekly injections. Beyond weight loss, Pfizer sees potential in diabetes, sleep apnea, and osteoarthritis. With its manufacturing muscle and experience from blockbuster drugs like Viagra, Pfizer aims to turn obesity treatment into a sustainable revenue stream—and possibly a personalized, cancer-like approach to tackling the booming obesity market. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/de13e2c8d813cd68","meta_description":"Pfizer is betting big on weight-loss drugs, unveiling promising data for berobenatide—a once-monthly shot that slashed 16% of body weight in trials. Acqui…","key_points":[],"chapters":[],"topics":[],"duration_seconds":114,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/vancouver-news-today-2-min-news-the-daily-news-now-7592122/episodes/pfizer-s-bold-move-in-weight-loss-drugs/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/vancouver-news-today-2-min-news-the-daily-news-now-7592122/pfizer-s-bold-move-in-weight-loss-drugs.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}